Form 4 for XENE Xenon Pharmaceuticals Inc.
Accepted 2021-12-07 00:00:00 ET · period of report 2021-12-06 · accession 0001209191-21-068300 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-07 | 2021-12-06 | XENE | Von Seggern Christopher | Chief Commercial Off | P - Purchase | $24.40 | +4,000 | 4,000 | New | +$97.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2021-12-06 | P | A | 4,000 | $24.40 | 4,000 | D | — | — |